Cargando…
Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery
Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter stu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958307/ https://www.ncbi.nlm.nih.gov/pubmed/33738167 http://dx.doi.org/10.7759/cureus.13324 |
_version_ | 1783664801450295296 |
---|---|
author | Akagündüz, Baran Akin Telli, Tugba Sezgin Goksu, Sema Yildirim, Hasan Cagri Ozer, Muhammet Göktaş Aydin, Sabin Ozyurt, Neslihan Karacin, Cengiz Paydas, Semra Dogan, Mutlu |
author_facet | Akagündüz, Baran Akin Telli, Tugba Sezgin Goksu, Sema Yildirim, Hasan Cagri Ozer, Muhammet Göktaş Aydin, Sabin Ozyurt, Neslihan Karacin, Cengiz Paydas, Semra Dogan, Mutlu |
author_sort | Akagündüz, Baran |
collection | PubMed |
description | Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter study, we aimed to demonstrate the real-world assessing prognostic factors and the effect of adjuvant treatment modalities in adult patients with HNSTS treated with upfront surgery. Methods We included a total of 47 patients who underwent curative-intent resection of a primary HNSTS between 2000 and 2019. Results The median follow-up was 29 months. The median age of patients was 51 years, and 66% of patients were male. The median relapse-free survival (RFS) of the study population was 31 months (range: 1.0-61.1 months), and the median overall survival (OS) was 115 months (range: 60.8-169.2 months). The univariable analysis revealed that treatment modalities showed a significant impact on RFS (p = 0.021); however, no difference was found in its impact on OS (p = 0.137). R0 resection did not showed impact on RFS (p = 0.130), but a significant association was found with OS (p = 0.004). In multivariable analysis, T stage of the tumor (hazard ratio [HR]: 3.834; 95% CI: 1.631-9.008; p = 0.002) and treatment with surgery and sequential RT and CT (HR: 0.115; 95% CI: 0.035-0.371; p < 0.001) were independent factors associated with RFS. R0 resection was independently associated with OS (HR: 4.902; 95% CI: 1.301-18.465; p = 0.019). Conclusion Our study revealed that R0 resection improved OS, and T3-4 stage of tumor was a negative independent factor for RFS in surgically resected HNSTS patients. The use of sequential CT and RT after resection was associated with a better RFS, which emphasizes the importance of multidisciplinary evaluation of the treatment of HNSTS. Randomized prospective studies are needed |
format | Online Article Text |
id | pubmed-7958307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-79583072021-03-17 Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery Akagündüz, Baran Akin Telli, Tugba Sezgin Goksu, Sema Yildirim, Hasan Cagri Ozer, Muhammet Göktaş Aydin, Sabin Ozyurt, Neslihan Karacin, Cengiz Paydas, Semra Dogan, Mutlu Cureus Radiation Oncology Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter study, we aimed to demonstrate the real-world assessing prognostic factors and the effect of adjuvant treatment modalities in adult patients with HNSTS treated with upfront surgery. Methods We included a total of 47 patients who underwent curative-intent resection of a primary HNSTS between 2000 and 2019. Results The median follow-up was 29 months. The median age of patients was 51 years, and 66% of patients were male. The median relapse-free survival (RFS) of the study population was 31 months (range: 1.0-61.1 months), and the median overall survival (OS) was 115 months (range: 60.8-169.2 months). The univariable analysis revealed that treatment modalities showed a significant impact on RFS (p = 0.021); however, no difference was found in its impact on OS (p = 0.137). R0 resection did not showed impact on RFS (p = 0.130), but a significant association was found with OS (p = 0.004). In multivariable analysis, T stage of the tumor (hazard ratio [HR]: 3.834; 95% CI: 1.631-9.008; p = 0.002) and treatment with surgery and sequential RT and CT (HR: 0.115; 95% CI: 0.035-0.371; p < 0.001) were independent factors associated with RFS. R0 resection was independently associated with OS (HR: 4.902; 95% CI: 1.301-18.465; p = 0.019). Conclusion Our study revealed that R0 resection improved OS, and T3-4 stage of tumor was a negative independent factor for RFS in surgically resected HNSTS patients. The use of sequential CT and RT after resection was associated with a better RFS, which emphasizes the importance of multidisciplinary evaluation of the treatment of HNSTS. Randomized prospective studies are needed Cureus 2021-02-13 /pmc/articles/PMC7958307/ /pubmed/33738167 http://dx.doi.org/10.7759/cureus.13324 Text en Copyright © 2021, Akagündüz et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Radiation Oncology Akagündüz, Baran Akin Telli, Tugba Sezgin Goksu, Sema Yildirim, Hasan Cagri Ozer, Muhammet Göktaş Aydin, Sabin Ozyurt, Neslihan Karacin, Cengiz Paydas, Semra Dogan, Mutlu Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery |
title | Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery |
title_full | Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery |
title_fullStr | Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery |
title_full_unstemmed | Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery |
title_short | Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery |
title_sort | assessment of prognostic factors and adjuvant treatment modalities in adult head and neck soft tissue sarcoma patients treated with upfront surgery |
topic | Radiation Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958307/ https://www.ncbi.nlm.nih.gov/pubmed/33738167 http://dx.doi.org/10.7759/cureus.13324 |
work_keys_str_mv | AT akagunduzbaran assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT akintellitugba assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT sezgingoksusema assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT yildirimhasancagri assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT ozermuhammet assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT goktasaydinsabin assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT ozyurtneslihan assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT karacincengiz assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT paydassemra assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery AT doganmutlu assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery |